Cargando…
Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica
BACKGROUND: In neuromyelitis optica (NMO), one of the underlying pathogenic mechanisms is the formation of antigen-antibody complexes which can trigger an inflammatory response by inducing the infiltration of neutrophils in lesions. Epithelial neutrophil-activating peptide 78 (ENA 78), known as Chem...
Autores principales: | Yang, Tao, Wang, Su, Zheng, Qi, Wang, Lei, Li, Qian, Wei, Mingyan, Du, Zongpan, Fan, Yongping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940958/ https://www.ncbi.nlm.nih.gov/pubmed/27401736 http://dx.doi.org/10.1186/s12883-016-0622-3 |
Ejemplares similares
-
Upregulation of Bcl-2 and Its Promoter Signals in CD4+ T Cells during Neuromyelitis Optica Remission
por: Yang, Tao, et al.
Publicado: (2017) -
Elevated Plasma Chemokines for Eosinophils in Neuromyelitis Optica Spectrum Disorders during Remission
por: Tong, Yanping, et al.
Publicado: (2018) -
Association of Pain with Plasma C5a in Patients with Neuromyelitis Optica Spectrum Disorders During Remission
por: Tong, Yanping, et al.
Publicado: (2022) -
GRP 78 antibodies are associated with clinical phenotype in neuromyelitis optica
por: Shimizu, Fumitaka, et al.
Publicado: (2019) -
GRP78 autoantibodies initiate the breakdown of the blood-brain barrier in neuromyelitis optica
por: Shimizu, Fumitaka, et al.
Publicado: (2017)